J. Claude Hemphill III – FDA Inspection, May 22, 2018

Record Details

This FDA Inspection record concerns J. Claude Hemphill III, with an inspection on May 22, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: J. Claude Hemphill III
Inspection Date: May 22, 2018
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Dustin R. Abaonza (Company Rep)

View Company Profile

ID · e411c21f-6533-4b48-84db-815e1097db5d

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1052856
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued

FDA Citations

21 CFR 312.62(a)Accountability records

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore J. Claude Hemphill III

FDA Inspection

J. Claude Hemphill IIIMay 22, 2018